Switzerland, Sierre, Techno-Pôle 4     +41791982082    swiss@iqdemy.ch

RUSSIAN AND CYPRUS SCIENTISTS are on the scent of a bioprinting discovery

RUSSIAN AND CYPRUS SCIENTISTS are on the scent of a bioprinting discovery

The Cyprus State University and IQJET ARTISIA Company are going to open the most advanced bioprinting laboratory next year.

The project is carrying out in collaboration with NextGene Biosystem (Blagoveshchensk, Russia), Amur State Medical Academy (Amur region, Russia) and IQDEMY SA Holding (IQJET ARTISIA Company is a part of the Holding, Switzerland). NextGene Biosystem and Amur State Medical Academy are Russian science leading organizations of cell engineering and health technology scientific studies.

The research activity of this bioprinting laboratory is aimed at the development of diseases treatment, based on application of structural cell changes.

Today, the major joint project of IQ ARTISIA and NextGeneBiosystem is development of a innovative bioprinter to create a kind of artificial skin for patients with skin burns and scalds as well as trophic ulcer.

Bioprinting laboratory is supposed to be a result of long-term collaboration of IQDEMY SA and NextGene. The joint research in bioprinting area started in chemical laboratory IQDEMY CHEMISTRY in Novosibirsk, Russia.The laboratory is located in Novosibirsk Akademgorodok, that is a concentration space of companies, acting in IT, pharmaceuticals, metallurgy and fossil fuels and due to this fact this area is sometimes called Silicon Forest. IQDEMY CHEMISTRY makes researches in the field of material rheological properties, bio-ink researches, bioprinter engineering, that meets both biotechnology and digital printing requirements.

Bioprinting and 3D printing are very perspective lines of research nowadays because the solution for bio-cellular printing will definitely forward breakthrough in medical science and implantology.

This is the reason why bioprinting industry becomes so popular among scientists and potential investors and is raised with ever increasing frequency as a topic discussed by scientific communities. One of the significant events in this field, The Biointerfaces International Conference, took place in Switzerland last August. The conference was organized by University of Zurich. At the conference, Doctor George Güttinger specified the need for development of Bioprinting laboratory in Europe, that would satisfy the world needs in such technology.

This idea inspired ARTISIA IQJet company and initiates the meeting of Vladislav Mirchev (IQDEMY SA President), Olga Kondratieva (IQDEMY SA Development Director) and The Head of University of Cyprus. Vladislav Mirchev and Olga Kondratieva act as ARTISIA IQJet Company representatives. The meeting was organized by KPMG Company. KPMG is a professional service company, being one of the Big Four auditors, along with Deloitte, EY and PwC, for another hand KPMG is official ARTISIA IQJet auditor. On the part of KPMG Mr. Angelos M Gregoriades (KPMG Cyprus Chairman) and Mr. Tassos Yiasemides (KPMG Cyprus Board Member) attended the event.

In that meeting companies’ representatives discussed possibilities of joint investment in bioprinting laboratory project. In the course of the talks Artisia IQJet and University of Cyprus decided to start the common scientific project of bioprinting industry researching and development.

Project initiators are sure, that research base of NextGene Biosystem, Amur State Medical Academy and IQDEMY Chemistry in collaboration with theoretical base of European Scientists will help to reach scientific breakthroughs in bioprinting sphere.

As reference:

ARTISIA IQJet Company is IQDEMY SA Holding sub-company. It was founded in 2016. Company’s owners are Vladislav Mirchev (50%) and Olga Kondratieva (50%). Registered capital is EUR 100 000 as well additional issue amounting to EUR 900 000 is provided. The company works with digital printing, bioprinting, printing supplies trading. ARTISIA IQJet Company has operating accounts in BANK OF CYPRUS and EUROBANK.

NextGene Biosystem Company is newly founded scientific company, which aggregate variety activities in medical research. Company is focusing on applied research in the most promising emerging technologies in biomedicine with emphasis on technology transfer and commercialization to different sphere of life. Research an NGB is encouraging partnerships among various disciplines as well as with other educational institutes, private enterprise and government agencies. The main partner on the part of government is Amur State Medical Academy, leading by Mr.Sergey Belugin. Since 1992 the Academy cooperates with the Japan-Russian Medical Exchange Foundation. From 2004 NGB cooperates with Heilogjiang University of Chinese Medicine (China) .

University of Cyprus was established by the Republic of Cyprus in 1989. It has approximately 7000 students (2013/2014). Based in the capital of Cyprus, Nicosia, teaching is mainly in Greek. The official languages are Greek and Turkish. There are eight faculties, including Faculty of Engineering and the Medicine School. The head of University of Cyprus is Constantinos Christofides.

KPMG is a professional service company, being one of the Big Four auditors, along with Deloitte, EY and PwC. Seated in Amsterdam, the Netherlands, and has three lines of services: audit, tax, and advisory. Its tax and advisory services are further divided into various service groups. KPMG was founded in 1870. Global chairman of KPMG LLP is John B. Veihmeyer.

Comments (0)

Leave a comment

You are commenting as guest.

Marketing & exhibitions:
E-mail: om@iqdemy.ch
Tel.: +7 (383) 363-35-33
Service-center support:
E-mail: service@iqdemy.ch
Skype: service.iqdemy